Skip to main content

Table 7 Compounds considered for the training set

From: Novel glitazones as PPARγ agonists: molecular design, synthesis, glucose uptake activity and 3D QSAR studies

Compound

R′

Glucose uptake activity

lnGU

Predicted activity

Residual activity

CPD02

3.91

3.87

0.04

CPD03

4.39

4.36

0.03

CPD04

4.30

4.26

0.04

CPD05

4.20

4.15

0.05

CPD07

4.48

4.45

0.03

CPD08

4.50

4.40

0.10

CPD09

2.99

2.86

0.13

CPD10

3.73

3.64

0.09

CPD11

4.31

4.28

0.03

CPD12

4.27

4.23

0.04

CPD14

4.25

4.18

0.07

CPD15

3.81

3.78

0.03

CPD16

4.00

3.98

0.02

CPD17

3.56

3.49

0.07

CPD18

4.17

4.12

0.05

CPD19

4.50

4.48

0.02

CPD20

4.38

4.32

0.06

CPD21

4.44

4.45

0.01

CPD22

4.01

4.12

− 0.11

CPD23

3.69

3.61

0.08